ENDPOINTS

Chinese ADC biotech lets Hong Kong IPO filing lapse

Duality Biologics, an ADC startup that's attracted multiple biopharma partnerships, has let its plans to list on the Hong Kong Stock Exchange fizzle out. The Shanghai-based biotech's

Feb 25, 2025 - 18:32
 0
Chinese ADC biotech lets Hong Kong IPO filing lapse
Duality Biologics, an ADC startup that's attracted multiple biopharma partnerships, has let its plans to list on the Hong Kong Stock Exchange fizzle out. The Shanghai-based biotech's
Read More

Tags:

Previous Article

Black squirrels may be evolving due to roadkill in cities

Next Article

Automating Insurance Verification: A Game-Changer for Pre-Visit Payment Collection

Related Posts

Cerula Care raises $3.7M to support cancer patients’ mental health

Cerula Care raises $3.7M to support cancer patients’ me...

Feb 12, 2025  0

Syngene CEO departs; Lilly and AdvanCell sign radiotherapy partnership

Syngene CEO departs; Lilly and AdvanCell sign radiother...

Feb 13, 2025  0

#ASCOGU: Lilly’s early bladder cancer data hint at safety edge over J&J’s Balversa

#ASCOGU: Lilly’s early bladder cancer data hint at safe...

Feb 15, 2025  0